Cargando…

The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations

Regulatory T cells (Treg cells) are considered one of the main dynamic cell types within the immune system. Because Treg cells suppress immune responses, they have potential roles in immunological self-tolerance and may help to maintain immune homeostasis. Promoting Treg cell function and increasing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaini, Rana G., Al-Rehaili, Amani A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332959/
https://www.ncbi.nlm.nih.gov/pubmed/30693029
http://dx.doi.org/10.1155/2019/5981054
_version_ 1783387470242512896
author Zaini, Rana G.
Al-Rehaili, Amani A.
author_facet Zaini, Rana G.
Al-Rehaili, Amani A.
author_sort Zaini, Rana G.
collection PubMed
description Regulatory T cells (Treg cells) are considered one of the main dynamic cell types within the immune system. Because Treg cells suppress immune responses, they have potential roles in immunological self-tolerance and may help to maintain immune homeostasis. Promoting Treg cell function and increasing their numbers might be useful in treating autoimmune disorders, as well as preventing allograft rejection. However, studies of mice and humans demonstrate that Treg cells promote cancer progression and suppress antitumor immunity. Therefore, suppressing Treg cell function or reducing their numbers could support the immune system's response to pathogenic microorganisms and tumors. As a result, there is great interest in investigating the Treg cells role in the treatment of hematological and nonhematological malignancies. Consequently, Treg cells could be a fundamentally important target for pathologies of the immune system. Targeting effector Treg cells could help to distinguish and selectively decrease these cells while preserving other Treg cells needed to suppress autoimmunity. Currently, a promising way to treat malignancies and other autoimmune disorders is stem cell transplantation. Stem cell transplants (SCT) can help to manage the production of Treg cells and also may produce more efficient Treg cells, thereby suppressing clinical disease progression. Specifically, mature T cells within the engrafted stem cells mediate this SCT beneficial effect. During SCT, the recipient's immune system is replaced with a donor, which allows for improved immune system function. In addition, SCT can protect from disease relapse, as graft-versus-host disease (GvHD) in transplant patients can be protective against cancer recurrence. The current review will define the role of regulatory T cells in treatment of malignancy. Additionally, it will summarize current promising research regarding the utility of regulatory T cells in stem cell transplantation.
format Online
Article
Text
id pubmed-6332959
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63329592019-01-28 The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations Zaini, Rana G. Al-Rehaili, Amani A. J Oncol Review Article Regulatory T cells (Treg cells) are considered one of the main dynamic cell types within the immune system. Because Treg cells suppress immune responses, they have potential roles in immunological self-tolerance and may help to maintain immune homeostasis. Promoting Treg cell function and increasing their numbers might be useful in treating autoimmune disorders, as well as preventing allograft rejection. However, studies of mice and humans demonstrate that Treg cells promote cancer progression and suppress antitumor immunity. Therefore, suppressing Treg cell function or reducing their numbers could support the immune system's response to pathogenic microorganisms and tumors. As a result, there is great interest in investigating the Treg cells role in the treatment of hematological and nonhematological malignancies. Consequently, Treg cells could be a fundamentally important target for pathologies of the immune system. Targeting effector Treg cells could help to distinguish and selectively decrease these cells while preserving other Treg cells needed to suppress autoimmunity. Currently, a promising way to treat malignancies and other autoimmune disorders is stem cell transplantation. Stem cell transplants (SCT) can help to manage the production of Treg cells and also may produce more efficient Treg cells, thereby suppressing clinical disease progression. Specifically, mature T cells within the engrafted stem cells mediate this SCT beneficial effect. During SCT, the recipient's immune system is replaced with a donor, which allows for improved immune system function. In addition, SCT can protect from disease relapse, as graft-versus-host disease (GvHD) in transplant patients can be protective against cancer recurrence. The current review will define the role of regulatory T cells in treatment of malignancy. Additionally, it will summarize current promising research regarding the utility of regulatory T cells in stem cell transplantation. Hindawi 2019-01-01 /pmc/articles/PMC6332959/ /pubmed/30693029 http://dx.doi.org/10.1155/2019/5981054 Text en Copyright © 2019 Rana G. Zaini and Amani A. Al-Rehaili. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Zaini, Rana G.
Al-Rehaili, Amani A.
The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations
title The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations
title_full The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations
title_fullStr The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations
title_full_unstemmed The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations
title_short The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations
title_sort therapeutic strategies of regulatory t cells in malignancies and stem cell transplantations
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332959/
https://www.ncbi.nlm.nih.gov/pubmed/30693029
http://dx.doi.org/10.1155/2019/5981054
work_keys_str_mv AT zainiranag thetherapeuticstrategiesofregulatorytcellsinmalignanciesandstemcelltransplantations
AT alrehailiamania thetherapeuticstrategiesofregulatorytcellsinmalignanciesandstemcelltransplantations
AT zainiranag therapeuticstrategiesofregulatorytcellsinmalignanciesandstemcelltransplantations
AT alrehailiamania therapeuticstrategiesofregulatorytcellsinmalignanciesandstemcelltransplantations